Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$114M |
| 2 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$31.3M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$26.4M |
| 4 |
Tyler Technologies
TYL
|
+$25M |
| 5 |
Brown & Brown
BRO
|
+$18.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$249M |
| 2 |
CELG
Celgene Corp
CELG
|
+$231M |
| 3 |
Microsoft
MSFT
|
+$171M |
| 4 |
Alibaba
BABA
|
+$140M |
| 5 |
Amazon
AMZN
|
+$99.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.49% |
| 2 | Healthcare | 14.66% |
| 3 | Consumer Discretionary | 11.66% |
| 4 | Communication Services | 10.19% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
MSC Industrial Direct
MSM
$6.77B
| $6.76M | 0.01% |
86,200
+1,500
| +2% | +$111K |
|
977
National Health Investors
NHI
$3.5B
| $6.76M | 0.01% |
82,920
+1,600
| +2% | +$131K |
|
978
Semtech
SMTC
$12.4B
| $6.74M | 0.01% |
127,400
+1,900
| +2% | +$95.2K |
|
|
SAFM
979
DELISTED
Sanderson Farms Inc
SAFM
| $6.73M | 0.01% |
38,200
+800
| +2% | +$126K |
|
|
DOC
980
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $6.72M | 0.01% |
354,806
+6,200
| +2% | +$114K |
|
981
First Citizens BancShares
FCNCA
$25.6B
| $6.71M | 0.01% |
12,600
-100
| -0.8% | -$50.6K |
|
982
Pebblebrook Hotel Trust
PEB
$2.05B
| $6.71M | 0.01% |
250,112
+4,200
| +2% | +$111K |
|
|
CLGX
983
DELISTED
Corelogic, Inc.
CLGX
| $6.71M | 0.01% |
153,400
+1,600
| +1% | +$68.1K |
|
984
Strategic Education
STRA
$1.86B
| $6.68M | 0.01% |
42,038
+800
| +2% | +$111K |
|
985
Bankunited
BKU
$3.41B
| $6.66M | 0.01% |
182,100
-2,900
| -2% | -$101K |
|
986
Q2 Holdings
QTWO
$4.13B
| $6.65M | 0.01% |
82,000
+7,100
| +9% | +$546K |
|
987
FirstService
FSV
$6.18B
| $6.65M | 0.01% |
71,500
+1,200
| +2% | +$113K |
|
988
Steven Madden
SHOO
$3.46B
| $6.64M | 0.01% |
154,425
+1,000
| +0.7% | +$40.4K |
|
989
FirstCash
FCFS
$9.14B
| $6.63M | 0.01% |
82,212
+1,100
| +1% | +$92.5K |
|
990
Apple Hospitality REIT
APLE
$3.75B
| $6.62M | 0.01% |
407,110
+6,900
| +2% | +$112K |
|
991
Zurn Elkay Water Solutions
ZWS
$8.41B
| $6.61M | 0.01% |
420,805
+11,210
| +3% | +$161K |
|
|
MFA
992
MFA Financial
MFA
$931M
| $6.6M | 0.01% |
215,625
+3,675
| +2% | +$112K |
|
993
OneMain Financial
OMF
$7.51B
| $6.59M | 0.01% |
156,300
+2,600
| +2% | +$105K |
|
994
Viavi Solutions
VIAV
$10.6B
| $6.57M | 0.01% |
438,100
+7,800
| +2% | +$117K |
|
995
Weibo
WB
$1.88B
| $6.56M | 0.01% |
141,528
-71,158
| -33% | -$3.33M |
|
|
SIX
996
DELISTED
Six Flags Entertainment Corp.
SIX
| $6.55M | 0.01% |
145,300
+2,600
| +2% | +$120K |
|
997
RLI Corp
RLI
$5.87B
| $6.55M | 0.01% |
145,600
+3,200
| +2% | +$150K |
|
998
Neogen
NEOG
$2.59B
| $6.54M | 0.01% |
200,532
+4,200
| +2% | +$138K |
|
999
Interactive Brokers
IBKR
$41.4B
| $6.52M | 0.01% |
558,800
+22,000
| +4% | +$258K |
|
1000
Omnicell
OMCL
$1.72B
| $6.51M | 0.01% |
79,700
+2,100
| +3% | +$161K |
|
Similar funds
Swiss National Bank's Q4 2019 Portfolio in Review
As of Q4 2019, Swiss National Bank held 2,602 positions worth $97.5B, up 3.6% from $94.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Swiss National Bank withdrew a net $3.98B in Q4 2019, closing 96 positions and reducing 725 holdings. Its most notable exit was Celgene Corp, an estimated $231M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Swiss National Bank opened a new position in Match Group worth $14.7M.
- Swiss National Bank's largest Q4 2019 buy was Match Group: 179,200 shares worth $14.7M.
- Swiss National Bank added most to Bristol-Myers Squibb in Q4 2019, an estimated $114M increase.
- Swiss National Bank's biggest Q4 2019 reduction was Apple, cutting an estimated $249M.
- Swiss National Bank fully exited Celgene Corp in Q4 2019, selling an estimated $231M.
- Swiss National Bank's ten largest holdings make up 19% of its $97.5B portfolio in Q4 2019.
- Swiss National Bank opened 82 new positions and closed 96 in Q4 2019.
- Swiss National Bank's portfolio value rose 3.6% quarter-over-quarter to $97.5B.
Based on Swiss National Bank's 13F filing for Q4 2019, filed 6 Feb 2020.